|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.08 USD | +5.37% |
|
-9.36% | +4.21% |
| 06-05 | Jade Biosciences Closes Public Offering of Shares | MT |
| 06-04 | Jade Biosciences Prices $150 Million Public Offering | MT |
| Market Cap | 955M 828M 764M 715M 1.34B 91.4B 1.36B 9.11B 3.53B 44.06B 3.58B 3.51B 153B | P/E Ratio 2026 * |
-6.1x | P/E Ratio 2027 * | -6.15x |
|---|---|---|---|---|---|
| Enterprise Value | 767M 665M 613M 575M 1.07B 73.4B 1.1B 7.32B 2.83B 35.38B 2.88B 2.82B 123B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
99.07% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Jade Biosciences, Inc.
| 1 day | +5.37% | ||
| 1 week | -9.36% | ||
| Current month | -23.57% | ||
| 1 month | -35.32% | ||
| 3 months | +14.69% | ||
| 6 months | +8.36% | ||
| Current year | +4.21% |
| 1 week | 14.28 |  | 17.39 |
| 1 month | 14.28 | | 25.71 |
| Current year | 12.45 | | 28 |
| 1 year | 6.56 | | 28 |
| 3 years | 6.56 | | 28 |
| 5 years | 6.56 | | 28 |
| 10 years | 6.56 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tom Frohlich
CEO | Chief Executive Officer | 50 | 2025-04-27 |
Bradford Dahms
DFI | Director of Finance/CFO | 38 | 2025-07-13 |
Andrew King
CTO | Chief Tech/Sci/R&D Officer | 46 | 2025-04-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Dobmeier
CHM | Chairman | 57 | 2025-04-27 |
Tomas Kiselak
BRD | Director/Board Member | 39 | 2025-04-27 |
Erin Lavelle
BRD | Director/Board Member | 48 | 2025-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-11 | Free | General Counsel | 196,875 | 0.4280% | ||
| 02-11 | Free | Chief Financial Officer | 264,688 | 0.5754% | ||
| 02-11 | Free | Chief Technology Officer | 288,750 | 0.6277% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.37% | -9.36% | +128.73% | - | 955M | |
| +1.20% | +3.13% | -14.16% | -10.86% | 42.96B | |
| +3.50% | -4.15% | +265.85% | +484.30% | 31.73B | |
| -0.61% | -3.11% | +14.00% | -12.36% | 30.22B | |
| -1.27% | -7.02% | -0.82% | +20.47% | 28.94B | |
| -0.66% | -5.84% | +7.59% | +12.76% | 23.87B | |
| +2.01% | +3.57% | +57.15% | +128.55% | 13.57B | |
| +0.09% | -0.80% | +6.59% | +8.13% | 12.96B | |
| +2.77% | -1.48% | - | - | 13.39B | |
| +0.68% | -1.74% | +103.98% | +81.60% | 12.2B | |
| Average | +1.31% | -2.73% | +63.21% | +89.07% | 21.08B | |
| Weighted average by Cap. | +0.81% | -2.43% | +54.00% | +92.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -172M -149M -138M -129M -241M -16.49B -246M -1.64B -636M -7.95B -647M -633M -27.64B | -191M -166M -153M -143M -268M -18.33B -274M -1.83B -707M -8.84B -719M -703M -30.72B |
| Net Debt | -188M -163M -150M -141M -263M -17.99B -269M -1.79B -694M -8.67B -705M -690M -30.15B | -429M -373M -343M -322M -601M -41.12B -614M -4.1B -1.59B -19.82B -1.61B -1.58B -68.91B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 16.08 $ | +5.37% | 806,446 |
| 26-06-10 | 15.26 $ | +0.26% | 1,375,102 |
| 26-06-09 | 15.22 $ | +1.60% | 1,598,187 |
| 26-06-08 | 14.98 $ | -11.57% | 1,466,488 |
| 26-06-05 | 16.94 $ | -4.51% | 2,600,892 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- JBIO Stock
Select your edition
All financial news and data tailored to specific country editions
